Custom CRISPR Multiplex sgRNA Vectors

abm’s Custom CRISPR Multiplex sgRNA system allows for optimal expression of multiple sgRNAs from alternating U6 and H1 RNA pol III promoters on a single lentiviral vector. This allows for expression of multiple sgRNAs targeting a single gene or multiple sgRNAs targeting multiple different genes. sgRNAs may be designed for use with any Cas9 variant, which is expressed from a separate vector. Together, the Multiplex sgRNA Vectors expand the CRISPR toolkit allowing for highly diverse gene editing applications. Inquire with us below to get started on your custom CRISPR project. 

Applications:

Service Details

Cloning Services
sgRNA Service (for spCas9) No. of sgRNAs Unit Cat. No. Price
Custom CRISPR Dual sgRNA Lentivector (for spCas9) 2 1.0 µg C420
Custom CRISPR Triple sgRNA Lentivector (for spCas9) 3 1.0 µg C421
Custom CRISPR Quad sgRNA Lentivector (for spCas9) 4 1.0 µg C422
Custom CRISPR Multiplex sgRNA Lentivector (for spCas9) >4 1.0 µg C423 Starting at
sgRNA Service (for saCas9) No. of sgRNAs Unit Cat. No. Price
Custom CRISPR Dual sgRNA Lentivector (for saCas9) 2 1.0 µg C511
Custom CRISPR Triple sgRNA Lentivector (for saCas9) 3 1.0 µg C512
Custom CRISPR Quad sgRNA Lentivector (for saCas9) 4 1.0 µg C513
Custom CRISPR Multiplex sgRNA Lentivector (for saCas9) >4 1.0 µg C514 Starting at
Lentivirus Packaging Services
Scale Application Purification Typical Titer Volume Cat. No. Price
Mini Cell culture Supernatant >2x108 IU/ml 3 x 250 μl LV001‑b
Regular Cell culture Gradient >2x109 IU/ml 4 x 100 μl LV001‑c
Ultra-Pure In vivo Ultracentrifuge >5x1010 IU/ml 10 x 50 μl LV001‑d
96-Well Cell culture Supernatant >1x107 IU/ml 100 μl/well LV001‑e

Additional Info

Workflow

* The vector for our CRISPR Multiplex sgRNA lentivectors is pLenti-Multi-sgRNA-PGK-Neo.

Additional Resources

FAQs

What promoter(s) are used in the Multiplex sgRNA vectors?
sgRNAs are expressed from alternating U6 and H1 promoters.
What is the approximate time frame to generate CRISPR lentiviral constructs?
The typical lead time is around 2-3 weeks for CRISPR lentivectors and 2-3 weeks for lentiviruses. Please inquire for a more accurate lead time.

Citations

01 Metzger D. et al. "Host Cell Transcriptional Tuning with CRISPR/dCas9 to Mitigate the Effects of Toxin Exposure." ACS Synth. Biol. (2022) 11, 3657-3668. doi: 10.1021/acssynbio.2c00214
02 Shirasaki, T. et al. "Nonlytic Quasi-Enveloped Hepatovirus Release Is Facilitated by pX Protein Interaction with the E3 Ubiquitin Ligase ITCH." J. Virol. (2022) 96(21). doi: 10.1128/jvi.01195-22